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Abstract Structurally intact and functionally active human 
bone alkaline pbosphatase was isolated from clavicle fragments 
of IDU, an Egyptian mummy of the Old Kingdom (2150 + 50 
BC). Both anion exchange and affinity chromatographies were 
employed to optimise the preparation of the ancient enzyme re- 
sulting in a specific activity of 180 * 30 mU/mg. The intactness 
of the bone enzyme fractions of the wheat-germ lectin affinity 
chromatography was successfully demonstrated in an ELISA 
using the monoclonal antibody BAP A. Fortunately, the mummi- 
fied bone was not contaminated by fungi or bacteria. 
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1. Introduction 
Amplification of ancient oligo- or polynucleotides allows the 
assignment of a specific human being and is a most valuable 
tool in molecular archaeology to ascertain the route of how the 
respective human population has settled [ 11, Our knowledge on 
the mode of conservation of functionally intact enzymes is 
limited. Remnants or even the complete molecular architecture 
of ancient proteins have been repeatedly demonstrated [2]. 
Their functional side remains uncertain. An active core protein 
of Cu,Zn, superoxide dismutase was obtained from air dried 
human brain (1200 BC) [3] and enzymic active alkaline phos- 
phatase, a di-zinc magnesium enzyme (Fig. l), was successfully 
isolated from bone samples of a ptolemeic mummy which was 
thoroughly pre-treated with balm components [5]. The benefi- 
cial aspect for the conservation of the alkaline phosphatase was 
assigned to the balm components as well as to the hydroxyl 
apatite bone mineral which was thought to serve as a most 
effective ‘ion exchange matrix’ for the binding of structurally 
intact and catalytically active proteins. 
It was of interest to evaluate the time dependent limitation 
for the catalytic activity and the molecular architecture of the 
ancient alkaline phosphatase in bone samples dating back to 
the Old Kingdom of ancient Egypt. Clavicle fragments of a 
4000-years-old Egyptian mummy called IDU (2150 f 50 BC) 
were examined for both enzymically and structurally intactness. 
The preparation technique of the ancient enzyme was substan- 
tially improved employing both anion exchange and affinity 
chromatography on wheat germ lectin agarose. Proof of the 
unequivocal human origin of the ancient alkaline phosphatase 
was challenged in a specific ELISA using a monoclonal anti- 
body directed to the human bone enzyme. This approach 
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Fig. 1. Schematic view of the co-catalytic zinc binding site of 
Escherichia coli alkaline phosphatase [4]. 
should strongly ascertain that the enzyme, if still detectable, can 
clearly be attributed to its human origin. 
2. Material and methods 
2.1. Preparation of bone Zn,Mg alkaline phosphatase 
All steps were performed at 4°C. Clavicle fragments of IDU, an 
Egyptian mummy of the Old Kingdom (2150 f 50 BC) were sand- 
blasted using chromatographically pure aluminium oxide under sterile 
conditions to minimise contamination with contemporary alkaline 
phosphatase. 
0.5 g fragments were finely ground in a porcelain mortar and sus- 
pended in 5 ml Tris buffer (pH 7.4) containing three protease inhibitors 
and detergent under slight agitation for 16 h as reported previously [5]. 
The first separation was performed by gel chromatography on a Hi- 
Load 16/60 Superdex 200 prep grade column equilibrated with elution 
buffer (20 mM Tris acetate (pH 7.4), 2 mM magnesium acetate and 
0.1% (v/v) Triton X-100). Two ml fractions were collected and assayed 
for protein concentration and alkaline phosphatase activity at 23°C as 
described [5] using 1.8 mM p-nitrophenyl phosphate in I M dietha- 
nolamine and 0.5 mM magnesium acetate (pH 9.6) as substrate buffer. 
The active fractions were collected, concentrated and passed through 
an anion exchange column (Resource Q, 6.4 x 30 mm, Pharmacia) 
previously equilibrated with elution buffer (pH 8.2). Alkaline phosphat- 
ase was eluted with the same buffer containing 100 mM LiCl and the 
enzyme containing fractions were pooled, concentrated and affinity 
chromatographed on a wheat germ lectin agarose column (5 x 1 cm, 
Pharmacia). The column was initially equilibrated with elution buffer 
(pH 8.0) and elution was performed with 500 mM N-acetyl-o-glucosam- 
ine. Alternatively to the above mentioned first preparation the extract 
of the second preparation was gel filtrated as described above and the 
alkaline phosphatase containing fractions were applied directly on a 
wheat germ lectin agarose column. 
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alkaline phosphatase [U/l] 
J 
f ig. 2. Binding of monoclonal antibody BAP A to the bone extract of 
I .XJ and to the contemporary human bone alkaline phosphatase in an 
I LISA based on the enzymic activity of the bound antigen. ??, contem- 
r >rary enzyme; A, IDU: x1 control (without BAP A). 
; 2. ELISA 
In order to examine the intactness and the human origin of the 
i&olated alkaline phosphatase from ancient human bone, binding to a 
nlonoclonal anti-human bone alkaline phosphatase antibody (BAP A) 
v as tested in an enzyme-linked immunosorbent assay (ELISA) [6] 
b Ised on the activity of the antibody-bound enzyme-antigen. 
For the antibody production Balblc mice were immunized with bone 
f:,LP [7]. Monoclonal antibodies BAP were produced using spleen cells 
1’ hich were fused with myeloma cells [8]. The obtained hybridomas 
I ere tested for antigen affinity. The positive ones were employed for 
t le production of tumours in mice. 
In ELISA all adsorption steps were performed in volumina of 100 
,L I each per well on a microtitre plate, the wash steps were carried out 
i L volumina of 200 ~1 per well. The wells were coated with goat anti- 
rIouse IgG (Calbiochem) (50 &ml) in phosphate buffer pH 6.5 (46 
I tM KH,PO,, 21 mM Na2HP0,) for 16 h at 23”C, then washed twice 
\ ith 1.25% a-lactose monohydrate, 0.5% bovine serum albumin, 0.1% 
PlaN,, and once with wash buffer (50 mM Tris-HC1 pH 7.5, 0.1% 
1 ovine serum albumin, 0.1% sulphobetain 14, 100 mM NaCl). The wells 
\ ere incubated for l-2 h at 23°C with BAP A (50&m]) in wash buffer. 
hfter two further washes a non-immune mouse serum (Calbiochem), 
‘~Q,ug/ml in wash buffer, was added to the wells for I hat 23”C, followed 
1 y washing as above. The coated wells were incubated with enzymically 
z etive antigen in dilution series overnight at 4°C in wash buffer. After 
1 ,ashing a substrate buffer (IO mM p-nitrophenyl phosphate in 1 M 
t iethanolamine, 0.5 mM magnesium acetate pH 9.6) was added and the 
i nmation of p-nitrophenol was allowed to develop for 1-2 h at 23°C. 
“‘he increasing absorption at 405 nm was recorded on a microplate 
I .:ader. All assays were performed in triplicate. Controls were made 
c mitting the BAP antibody respectively the alkaline phosphatase. 
‘able 1 
\Ikaline phosphatase activity in extracts of clavicle fragments 
1 St preparation 
3. Results and discussion 
3.1. Preparation of ancient bone alkaline phosphatase 
In a previous study the successful isolation of a 2300 years 
aged bone alkaline phosphatase being essentially identical to 
the contemporary enzyme was reported [5]. The time depend- 
ency on the intactness of ancient bone alkaline phosphatase was 
examined using portions of a clavicle taken from an Egyptian 
mummy called IDU (21.50 ? 50 BC). During the initial gel 
chromatography the elution profile was essentially similar to 
that of the pattern obtained with the earlier ptolemeic bone 
extract [S]. The recovered ancient enzyme had a relative molec- 
ular mass of M, = 190 ? 20 kDa, thus, being close to the con- 
temporary enzyme (A4, = 200 kDa). The specific activity rose 
to about 40 and 57 mU/mg protein (Table 1) resembling 
40 + 7% of the activity of the ptolemeic enzyme mentioned 
above and 22 ? 4% to that of the contemporary enzyme. Anion 
exchange chromatography diminished the enzymic activity to 
half of the initial value. This is in contrast to the results ob- 
tained with the ptolemeic mummy extract which resulted in a 
2-fold activity increase. The specific activity of the 4000 years 
aged alkaline phosphatase did not significantly increase using 
affinity chromatography on wheat germ lectin agarose. (Table 
1). Thus another preparation route was devised and carried out. 
After gel filtration the enzymically active fractions were directly 
applied to an affinity column. A 4- to j-fold enrichment in 
activity was detected amounting to 180 + 30 mU/mg protein. 
Unlike to the catalytic activity of the ptolemeic and contempo- 
rary enzymes, which survived overnight storage at -8O”C, the 
IDU enzyme lost its activity completely. These observations 
substantially support the conclusion that the alkaline phosphat- 
ase can be attributed to an ancient active protein which was 
safely docked for 4000 years to the apatite in the mummified 
bone. 
As alkaline phosphatase is likewise abundant in microorgan- 
isms, control experiments were carried out to exclude the pos- 
sible overlapping enzyme activity originating from microbial 
contamination. No anaerobic or aerobic bacteria as well as 
fungi could be detected in comprehensive microbial assays em- 
ploying the earlier described protocol [5]. 
3.2. ELBA 
The immunoreactivity of a monoclonal antibody (BAP A) 
against contemporary and ancient alkaline phosphatases was 
tested in an ELISA developed by p-nitrophenol formation in 
the presence of enzymically active alkaline phosphatase bound 
2nd preparation 
Protein @g/g bone) Specific activity (mU/mg) Protein &g/g bone) Specific activity (mU/mg) 
( +el filtration 480 + 40 51 f 5 560 f 30 40 f 2 
\nion exchange chromatograpy 140f3 22 f 1 
affinity chromatography 20 + 2 52 f 2 15+ 1 180 2 30 
1 .5 g finely ground pelvis fragments were suspended in Tris buffer containing protease inhibitors and detergent under slight agitation for 18 h at 
- “C. During all preparation steps alkaline phosphatase activity and protein concentration [S] were assayed. The extract was gel filtrated on a Superdex 
.‘OO column (Pharmacia). In the first preparation alkaline phosphatase containing fractions were concentrated and passed through an anion exchange 
I olumn. After concentration of the eluate affinity chromatography on a wheat germ lectin-agarose column was performed. The column was initially 
<,quilibrated with Tris buffer (pH 8.0) and eluted with the same buffer containing 500 mM N-acetyl-D-glucosamine. In the second preparation the 
.Ilkaline phosphatase containing fractions of the gel filtration were applied directly to the affinity chromatography. 
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to the antibody. A significant immunoactivity between the an- 
cient enzyme and the monoclonal antibody BAP A is detectable 
(Fig. 2). The decrease in immunoactivity of the antibody to the 
ancient enzyme may be due to the loss of some carbohydrate 
moieties, decomposition or modification of some amino acids 
or partial conformational change of the protein. The epitope 
which is recognised by BAP A is assumed to be of a marked 
stability which is less susceptible to age related deterioration 
processes of many an amino acid residue in the polypeptide 
chain 
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